Article
SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma.
Cancer research - 2 Jul 2025
Sen Utsav, Coleman Charles, Gandhi Nishant, Jethalia Vrinda, Demircioglu Deniz, Elliott Andrew, Vanderwalde Ari M, Hayatt Omar, de Stanchina Elisa, Halmos Balazs, Ma Patrick C, Berisa Mirela, Hasson Dan, Sen Triparna
Abstract excerpt
Concurrent inactivating mutations in STK11 and KEAP1 drive primary resistance to therapies, leading to worse outcomes in KRAS-mutated lung adenocarcinoma (KRASmut LUAD), and are associated with metabolic alterations. Elucidation of the underlying biology of this aggressive LUAD subset is needed to develop effective treatments to improve patient outcomes. Our transcriptomic analysis of 5,498 "real-world" KRASmut...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
